Research Articles

Bechard, A. R., LaCrosse, A., Namba, M. D., Jackson, B., & Knackstedt, L. A. (2018). Impairments in reversal learning following short access to cocaine self-administration. Drug and alcohol dependence, 192, 239-244.

Logan, C. N., LaCrosse, A. L., & Knackstedt, L. A. (2018). Nucleus accumbens GLT-1a overexpression reduces glutamate efflux during reinstatement of cocaine-seeking but is not sufficient to attenuate reinstatement. Neuropharmacology, 135, 297-307.

LaCrosse, A. L., O'Donovan, S. M., Sepulveda-Orengo, M. T., McCullumsmith, R. E., Reissner, K. J., Schwendt, M., & Knackstedt, L. A. (2017). Contrasting the role of xCT and GLT-1 upregulation in the ability of ceftriaxone to attenuate the cue-induced reinstatement of cocaine seeking and normalize AMPA receptor subunit expression. Journal of Neuroscience, 37(24), 5809-5821.

LaCrosse, A. L., Hill, K., & Knackstedt, L. A. (2016). Ceftriaxone attenuates cocaine relapse after abstinence through modulation of nucleus accumbens AMPA subunit expression. European Neuropsychopharmacology, 26(2), 186-194.

LaCrosse, A., B Taylor, S., E Nemirovsky, N., T Gass, J., & F Olive, M. (2015). mGluR5 positive and negative allosteric modulators differentially affect dendritic spine density and morphology in the prefrontal cortex. CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS & Neurological Disorders), 14(4), 476-485. pmid:25921744

LaCrosse, A. L., Burrows, B. T., Angulo, R. M., Conrad, P. R., Himes, S. M., Mathews, N., ... & Olive, M. F. (2015). mGluR5 positive allosteric modulation and its effects on MK-801 induced set-shifting impairments in a rat operant delayed matching/non-matching-to-sample task. Psychopharmacology, 232(1), 251-258.

Prus, A. J., Hillhouse, T. M., & LaCrosse, A. L. (2014). Acute, but not repeated, administration of the neurotensin NTS1 receptor agonist PD149163 decreases conditioned footshock-induced ultrasonic vocalizations in rats. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 49, 78-84.

Loweth, J. A., Scheyer, A. F., Milovanovic, M., LaCrosse, A. L., Flores-Barrera, E., Werner, C. T., ... & Szumlinski, K. K. (2014). Synaptic depression via mGluR1 positive allosteric modulation suppresses cue-induced cocaine craving. Nature neuroscience, 17(1), 73.

Hicks, M. P., Wischerath, K. C., Lacrosse, A. L., & Olive, M. F. (2012). Increases in doublecortin immunoreactivity in the dentate gyrus following extinction of heroin-seeking behavior. Neural plasticity, 2012.

Review Articles

Tomek, S., Lacrosse, A., Nemirovsky, N., & Olive, M. (2013). NMDA receptor modulators in the treatment of drug addiction. Pharmaceuticals, 6(2), 251-268.

LaCrosse, A., & Foster Olive, M. (2013). Neuropeptide systems and schizophrenia. CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS & Neurological Disorders), 12(5), 619-632.

Encyclopedia and Book Chapters

LaCrosse, A. L., Stennett, B., & Knackstedt L.A. (2017). Polysubstance-related disorders. The SAGE Encyclopedia of Abnormal and Clinical Psychology. Wenzel AE (ed.) DOI:

LaCrosse, A.L., & Jackson, B.S. (2017). Antipsychotic Medications. The SAGE Encyclopedia of Abnormal and Clinical Psychology. Wenzel AE (ed.) DOI:

Holly, E.N., LaCrosse, A.L., & Hillhouse, T.M. (2013) Group I and Group II Metabotropic Glutamate Receptors: Role in Pathophysiology and Treatment of Major Depressive Disorder. Metabotropic Glutamate Receptors, Molecular Mechanisms, Role in Neurological Disorders and Pharmacological Effects, 2013, 7: 135-150.